Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome

A scientific statement from the American Heart Association

American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, Council on Functional Genomics Translational Biology, Council on the Kidney in Cardiovascular Disease, Council on Quality of Care and Outcomes Research

Research output: Contribution to journalArticle

27 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1123-1149
Number of pages27
JournalCirculation
Volume131
Issue number12
DOIs
StatePublished - 2015
Externally publishedYes

Keywords

  • Acute coronary syndrome
  • AHA Scientific Statements
  • Chronic kidney disease
  • Kidney disease
  • Pharmacotherapy

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, Council on Functional Genomics Translational Biology, Council on the Kidney in Cardiovascular Disease, & Council on Quality of Care and Outcomes Research (2015). Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: A scientific statement from the American Heart Association. Circulation, 131(12), 1123-1149. https://doi.org/10.1161/CIR.0000000000000183

Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome : A scientific statement from the American Heart Association. / American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Cardiovascular Surgery and Anesthesia; Council on Functional Genomics Translational Biology; Council on the Kidney in Cardiovascular Disease; Council on Quality of Care and Outcomes Research.

In: Circulation, Vol. 131, No. 12, 2015, p. 1123-1149.

Research output: Contribution to journalArticle

American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, Council on Functional Genomics Translational Biology, Council on the Kidney in Cardiovascular Disease & Council on Quality of Care and Outcomes Research 2015, 'Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: A scientific statement from the American Heart Association', Circulation, vol. 131, no. 12, pp. 1123-1149. https://doi.org/10.1161/CIR.0000000000000183
American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, Council on Functional Genomics Translational Biology, Council on the Kidney in Cardiovascular Disease, Council on Quality of Care and Outcomes Research. Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: A scientific statement from the American Heart Association. Circulation. 2015;131(12):1123-1149. https://doi.org/10.1161/CIR.0000000000000183
American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology ; Council on Cardiovascular Surgery and Anesthesia ; Council on Functional Genomics Translational Biology ; Council on the Kidney in Cardiovascular Disease ; Council on Quality of Care and Outcomes Research. / Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome : A scientific statement from the American Heart Association. In: Circulation. 2015 ; Vol. 131, No. 12. pp. 1123-1149.
@article{8243f27f67b44fbf9c6da9bd33374a57,
title = "Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: A scientific statement from the American Heart Association",
keywords = "Acute coronary syndrome, AHA Scientific Statements, Chronic kidney disease, Kidney disease, Pharmacotherapy",
author = "{American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology} and {Council on Cardiovascular Surgery and Anesthesia} and {Council on Functional Genomics Translational Biology} and {Council on the Kidney in Cardiovascular Disease} and {Council on Quality of Care and Outcomes Research} and Washam, {Jeffrey B.} and Herzog, {Charles A.} and Beitelshees, {Amber L.} and Cohen, {Mauricio G} and Henry, {Timothy D.} and Kapur, {Navin K.} and Mega, {Jessica L.} and Venu Menon and Page, {Robert L.} and Newby, {L. Kristin}",
year = "2015",
doi = "10.1161/CIR.0000000000000183",
language = "English (US)",
volume = "131",
pages = "1123--1149",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome

T2 - A scientific statement from the American Heart Association

AU - American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology

AU - Council on Cardiovascular Surgery and Anesthesia

AU - Council on Functional Genomics Translational Biology

AU - Council on the Kidney in Cardiovascular Disease

AU - Council on Quality of Care and Outcomes Research

AU - Washam, Jeffrey B.

AU - Herzog, Charles A.

AU - Beitelshees, Amber L.

AU - Cohen, Mauricio G

AU - Henry, Timothy D.

AU - Kapur, Navin K.

AU - Mega, Jessica L.

AU - Menon, Venu

AU - Page, Robert L.

AU - Newby, L. Kristin

PY - 2015

Y1 - 2015

KW - Acute coronary syndrome

KW - AHA Scientific Statements

KW - Chronic kidney disease

KW - Kidney disease

KW - Pharmacotherapy

UR - http://www.scopus.com/inward/record.url?scp=84929328979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929328979&partnerID=8YFLogxK

U2 - 10.1161/CIR.0000000000000183

DO - 10.1161/CIR.0000000000000183

M3 - Article

VL - 131

SP - 1123

EP - 1149

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 12

ER -